Carsten Thiel, PhD, joined Abeona as Chief Executive Officer on April 2, 2018, bringing 25 years of proven global biopharmaceutical industry experience, including rare and orphan diseases. Prior to Abeona, Dr. Thiel was Executive Vice President & Chief Commercial Officer at Alexion, where he led a global commercial organization to deliver robust growth and execution on behalf of patients. Previously, he served as Senior Vice President, Europe/Middle East/Africa & Asia Pacific of Alexion where he was responsible for driving the Alexion’s global commercial operations, including maximizing the current portfolio as well as guiding the launch of anticipated new products and indications. Dr. Thiel had also managed the regional and global functions located at the European headquarters in Switzerland. Prior to joining Alexion, Dr. Thiel served as Vice President, Head of Europe at Amgen from 2011 to 2014, where he led regional operations and was responsible for products in hematology/oncology, nephrology, and bone disorders, and prepared for new product launches in inflammation and cardiology. Prior to Amgen, Dr. Thiel held sales and marketing leadership roles across Europe at Roche. Dr. Thiel has a Ph.D. in Molecular Biology and Biochemistry from the Max Planck Institute, Germany, and a Master’s Degree in Biochemistry from the University of Marburg, Germany.